EICHORCondition: Cancer · Sponsor: University of Chicago
The purpose of this study is to see if lactulose can improve the effectiveness of immunotherapy in patients with advanced cancer.
This description comes directly from the study's public registry record.
Clinical Trials Intake Intake · 8557028222 · cancerclinicaltrials@bsd.uchicago.edu
Always discuss trial participation with your own doctor first.
| University of Chicago Medicine Comprehensive Cancer Center | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07354100